Genesis Healthcare Inc (NYSE:GEN) COO Paul David Bach sold 12,418 shares of the firm’s stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $1.17, for a total value of $14,529.06. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Paul David Bach also recently made the following trade(s):

  • On Monday, June 3rd, Paul David Bach sold 8,616 shares of Genesis Healthcare stock. The shares were sold at an average price of $1.16, for a total value of $9,994.56.
  • On Monday, May 20th, Paul David Bach sold 11,540 shares of Genesis Healthcare stock. The shares were sold at an average price of $1.20, for a total value of $13,848.00.

NYSE GEN traded up $0.04 during trading hours on Friday, reaching $1.23. 351,844 shares of the stock traded hands, compared to its average volume of 260,343. Genesis Healthcare Inc has a 1 year low of $1.10 and a 1 year high of $2.86.

Genesis Healthcare (NYSE:GEN) last released its quarterly earnings results on Thursday, May 9th. The company reported ($0.15) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.25) by $0.10. The firm had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.17 billion. On average, analysts predict that Genesis Healthcare Inc will post -0.72 EPS for the current fiscal year.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc grew its position in Genesis Healthcare by 0.5% in the third quarter. Vanguard Group Inc now owns 2,424,601 shares of the company’s stock valued at $3,273,000 after acquiring an additional 12,253 shares during the period. Rhumbline Advisers grew its position in Genesis Healthcare by 51.3% in the fourth quarter. Rhumbline Advisers now owns 68,297 shares of the company’s stock valued at $81,000 after acquiring an additional 23,160 shares during the period. Acadian Asset Management LLC grew its position in Genesis Healthcare by 14.7% in the fourth quarter. Acadian Asset Management LLC now owns 1,691,866 shares of the company’s stock valued at $1,996,000 after acquiring an additional 217,438 shares during the period. California Public Employees Retirement System grew its holdings in shares of Genesis Healthcare by 8.4% during the fourth quarter. California Public Employees Retirement System now owns 383,258 shares of the company’s stock worth $452,000 after purchasing an additional 29,807 shares during the last quarter. Finally, Columbia Pacific Advisors LLC grew its holdings in shares of Genesis Healthcare by 1.0% during the fourth quarter. Columbia Pacific Advisors LLC now owns 3,229,829 shares of the company’s stock worth $3,811,000 after purchasing an additional 32,374 shares during the last quarter. Institutional investors and hedge funds own 21.34% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Genesis Healthcare Inc (NYSE:GEN) COO Paul David Bach Sells 12,418 Shares” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://www.thecerbatgem.com/2019/06/16/genesis-healthcare-inc-nysegen-coo-paul-david-bach-sells-12418-shares.html.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

Featured Article: How Investors Use a Balance Sheet

Insider Buying and Selling by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.